The neonatal narcotic abstinence syndrome: a brief review.
Because substance abuse experts are not available in many institutions, the consulting psychiatrist is required to diagnose and manage conditions such as the neonatal narcotic abstinence syndrome, which is readily recognized and treated. The authors discuss morbidity due to this syndrome in neonates born to narcotic addicted mothers. The clinical usefulness of neonatal narcotic abstinence scales is reviewed, with special reference to their application in treatment. The dosing of various drugs currently in use is also discussed.
D002746:Chlorpromazine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008691:Methadone / Q000627:therapeutic use; D009294:Narcotics / Q000009:adverse effects*; D009892:Opium / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000628:therapy
D009294:Narcotics; D009892:Opium; C017652:paregoric; D003975:Diazepam; D002746:Chlorpromazine; D008691:Methadone; D010634:Phenobarbital